News search

E.g., 20/10/2019
E.g., 20/10/2019
La Dra. Guadalupe Sabio en su laboratorio.
About the CNIC
25 Oct 2017

Dr. Sabio leads a research group at the Carlos III National Cardiovascular Research Center (CNIC) whose main line of research are diseases related to obesity, like cardiovascular diseases, diabetes and liver cancer.

The best way to start the day. A ‘high-energy’ breakfast could consist of a cup of coffee, milk or yogurt, fruit, and wholemeal bread with tomato and olive oil
3 Oct 2017

The PESA study shows that people who regularly eat a ‘low energy’ breakfast (supplying less than 5% of recommended daily calorie intake) double their risk of developing atherosclerosis independently of classical cardiovascular risk factors

3D ultrasound of the right carotid artery. An atherosclerotic plaque is visible as a small protrusion (arrow) in the vessel wall of the internal branch of the proximal carotid artery (bottom), close to the bifurcation. In contrast, the surface of the disease-free external branch (top) is smooth (asterisk).
24 Jul 2017

CNIC researchers show the value of total atherosclerosis burden for the identification of individuals at risk of cardiovascular disease

About the CNIC
1 Jun 2017

Dr. Ibáñez, Director of Clinical Research at the CNIC, has received an award for his contribution to the fight against cardiovascular diseases

10 Jan 2017

The findings, published in Nature Medicine, suggest a major potential for NOS2 inhibitors in the treatment of thoracic aortic aneurysa

Los participantes de la CNIC Conferenc
About the CNIC
2 Nov 2016

Mechanical forces are the major drivers of development, physiology, and diseases of the cardiovascular system

Adela M. Guaras, José Antonio Enriquez, Enrique Calvo, Sara Cogliati, Jesús Vázquez, Rocio Nieto-Arellano, Iakes Ezkurdia y Nadia Mercader.
26 Oct 2016

The study helps to explain how different forms of organization affect metabolism and are linked to the tendency to develop certain diseases

De pie: Prof. Jesús Vázquez, Prof. Francisco Sánchez-Madrid, Dra. Danay Cibrián y Dra. Pilar Martín. Sentados de Izda. a Dcha.: María Laura Sáiz, Dra. Hortensia de la Fuente, Dra. Alessia Ferrarini, Dra. Inmaculada Jorge, Raquel Sánchez-Díaz y Olga Moreno-Gonzalo.
5 Jul 2016

The study, published in Nature Immunology, opens the way to the possible use of CD69 as a therapeutic target for the control of this disease

Ignacio Flores, Juan M. Fernández-Alvira, Valentín Fuster, Vicente Andrés y Beatriz Dorado
24 May 2016

Half of patients with CVD show no above-normal risk of developing the disease on the basis of classical risk factors, such as high cholesterol, smoking, lack of exercise, and high blood pressure

Stanislao Travisano, José Luis de la Pompa, Gaetano D'Amato y Donal MacGrogan.
About the CNIC
25 Apr 2016

These genes form part of a signaling mechanism that is possibly altered in patients with a bicuspid aortic valve (BAV), a prevalent condition that compromises cardiovascular health